Pros And Cons Of FDA's Push For Nonprescription Drugs
By Heidi Gertner, Elizabeth Jungman and Eva Schifini · March 4, 2026, 5:04 PM EST
Under the leadership of Commissioner Martin Makary, the U.S. Food and Drug Administration is looking to dramatically expand access to nonprescription — often referred to as over-the-counter, or OTC — drugs....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login